Wugen

Wugen

July 15, 2022

Develops off-the-shelf cellular therapies for cancer

ProteXase Therapeutics

ProteXase Therapeutics

July 15, 2022

Focused on the rational drug discovery and development of sHAIs as a more effective treatment option for lung and colon cancer patients, including those which are resistant to current therapies

Metro International Biotech

Metro International Biotech

July 14, 2022

A privately-owned clinical-stage pharmaceutical company that has established the most comprehensive portfolio of proprietary NAD+ precursors in the world

Kalocyte

Kalocyte

July 14, 2022

Develops ErythroMer, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply

InvivoSciences

InvivoSciences

July 14, 2022

A precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues

Integro Theranostics

Integro Theranostics

July 14, 2022

A startup with the potential to revolutionize cancer treatment and is committed to improving outcomes for all patients

Hillmed

July 14, 2022

Develops diagnostic and therapeutic treatment devices for pelvic floor pain

Fimbrion Therapeutics

Fimbrion Therapeutics

July 12, 2022

Develops drugs for the prevention and treatment of infectious diseases caused by bacteria, including drug-resistant strains

Fertilplus Partners

Fertilplus Partners

July 12, 2022

A biotechnology company developing fertility drugs in the horse breeding industry

Cellatrix

Cellatrix

July 7, 2022

Developed patient-derived 3D culture system to recapitulate the complex biology of bone marrow microenvironment

Viewing 1 - 10 of 30